Teva Pharma Industries Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.7% | -13.3% | +1.0% | -1.3% | -2.7% | -7.2% | -7.2% | -3.7% | +0.7% | -5.8% | +1.0% | -1.7% | +4.8% | -2.5% | -11.2% | +2.8% | +11.9% | -10.6% | -1.8% | -0.6% | +5.5% | -10.7% | +3.4% | -5.0% | +8.0% | -5.7% | +5.9% | -0.7% | +15.8% | -14.3% | +9.0% | +4.0% | -2.4% | -8.0% | +7.3% | +7.3% | +5.2% | -15.5% | +4.0% | – | |
| – | +12.3% | -9.4% | +1.9% | +3.6% | -1.7% | -6.9% | -2.8% | -5.0% | +3.2% | -5.7% | +0.1% | -0.3% | +3.1% | -8.6% | -8.2% | +0.9% | +13.1% | -12.5% | -3.2% | +2.7% | -2.1% | -6.3% | +3.7% | -3.3% | +9.7% | -1.6% | +0.1% | -4.0% | +2.1% | +0.3% | +4.5% | +2.0% | -3.4% | -4.5% | +3.0% | +4.9% | -5.5% | -2.2% | -1.1% | – | |
| – | +21.0% | -16.8% | +0.1% | -6.3% | -3.8% | -7.6% | -12.2% | -1.9% | -2.5% | -5.9% | +2.1% | -3.4% | +7.0% | +5.4% | -14.5% | +5.0% | +10.6% | -8.3% | -0.3% | -4.2% | +14.3% | -15.1% | +3.1% | -7.0% | +6.1% | -10.6% | +13.5% | +3.1% | +30.5% | -26.7% | +14.3% | +6.1% | -1.3% | -11.5% | +12.0% | +9.6% | +15.3% | -25.8% | +9.2% | – | |
| – | +3.2% | -33.2% | +6.3% | +12.1% | -33.9% | -11.9% | -8.5% | +7.2% | -5.1% | -11.5% | +5.7% | -13.0% | +55.8% | -40.9% | +1.8% | +14.7% | +48.1% | -33.5% | -2.4% | -10.5% | +9.9% | -7.8% | +1.3% | -23.2% | +20.0% | +20.5% | +8.7% | -8.0% | -7.5% | +3.4% | +11.2% | -10.8% | +12.9% | -8.9% | -1.2% | +4.9% | +4.3% | -16.9% | +12.6% | – | |
| – | +0.3% | -24.1% | +15.3% | +21.3% | +49.1% | -33.1% | -4.0% | -2.2% | +11.3% | -15.1% | +1.4% | -3.7% | +11.9% | -4.7% | -13.2% | +5.7% | +17.2% | -11.3% | -16.6% | +20.2% | -4.8% | +6.9% | +5.7% | -9.6% | +1.8% | +2.8% | +3.7% | -12.7% | +9.0% | -4.8% | +1.8% | +5.3% | +1.3% | -1.7% | +2.7% | +3.9% | +15.8% | -17.2% | +4.3% | – | |
| – | +11.0% | -21.7% | +3.2% | +1.0% | -1.0% | -17.5% | -7.1% | +3.6% | +5.4% | -16.4% | +3.1% | -9.5% | +61.5% | +3.5% | -15.1% | +289.6% | -73.5% | -12.1% | -10.6% | -9.3% | +68.4% | +24.4% | +11.8% | -54.4% | +110.0% | -39.2% | +53.6% | -38.5% | +10.2% | +19.8% | +2.0% | +8.4% | -2.3% | -36.8% | +21.3% | -13.7% | +65.6% | -44.0% | +52.0% | – | |
| – | -117.9% | – | -741.3% | – | -3,543.7% | – | -100.9% | – | -19,875.0% | – | -580.6% | – | – | +29.1% | -9.4% | -2,609.8% | – | +6.9% | +34.1% | +7.0% | -87.5% | -1,014.1% | – | – | -304.1% | – | – | – | +119.8% | -128.8% | – | – | – | – | -12.3% | +93.8% | -66.0% | +117.3% | -77.1% | – | |
| – | +418.0% | -73.4% | +15.0% | +8.8% | -26.3% | +41.9% | -12.9% | -3.0% | -1.7% | -3.1% | -5.5% | +2.4% | -1.9% | +8.2% | -0.4% | -47.5% | +240.2% | -27.1% | -5.5% | -12.0% | -25.3% | +43.3% | -18.2% | +19.4% | +11.2% | -7.2% | +3.1% | +4.5% | -7.1% | -3.8% | -3.6% | +12.9% | +180.5% | -70.5% | -9.8% | +3.0% | +39.7% | -31.2% | -0.5% | – | |
| – | -248.6% | – | -968.9% | – | -11,199.2% | – | -119.9% | – | – | – | – | – | – | -117.6% | – | – | – | -19.7% | +117.0% | +18.8% | -146.2% | – | – | -74.3% | -766.7% | – | – | – | +693.8% | -192.7% | – | – | – | – | -30.6% | +217.6% | -86.0% | +379.1% | -204.4% | – | |
| – | -72.5% | -5.3% | -140.7% | – | – | – | -265.2% | – | – | – | -2,088.9% | – | +981.8% | -149.6% | – | – | +31.2% | +195.2% | +58.1% | -22.4% | -131.6% | – | +44,900.0% | -88.1% | +43.9% | -87.7% | -15.8% | -175.0% | – | -226.8% | – | -89.0% | -59.4% | +164.3% | -205.4% | – | -282.2% | – | +80.6% | – | |
| – | -379.6% | – | -1,129.3% | – | -2,276.4% | – | -116.7% | – | – | – | – | – | – | -36.7% | +102.9% | -3,206.4% | – | -48.7% | +168.8% | +41.1% | -154.5% | – | – | – | -2,280.4% | – | – | – | +571.0% | -130.0% | – | – | – | – | +31.8% | +53.5% | +10.9% | -23.1% | -256.1% | – | |
| – | -107.4% | – | -475.5% | – | -989.7% | – | -77.1% | +140.4% | -344.0% | – | -133.6% | – | +236.1% | -47.1% | -6.1% | -815.0% | – | -27.5% | +10.9% | +15.7% | -77.8% | -259.7% | – | -26.8% | -179.3% | – | +20.8% | -35.4% | +141.9% | -96.4% | +347.3% | -15.9% | +461.4% | -18.0% | -31.1% | +68.0% | -42.8% | +38.8% | -102.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.